Announcement of the Advisory Panel on Outreach and Education (APOE) July 28, 2021 Virtual Meeting, 36749-36751 [2021-14830]

Download as PDF Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices jbell on DSKJLSW7X2PROD with NOTICES and (II) full Technical Report and Appendixes. The purpose of the public comment period is to obtain comments on the draft report. Comments are being sought from individuals including scientists and representatives from various government agencies, industry, labor, and other stakeholders, and also the public. If there are errors of fact, unsubstantiated claims, evidence of careless experimental work, inclusion of too much information already in the literature, or statements that are inaccurate, please note such in your review comments. The authors ask that special emphasis be placed on technical review of the following issues: 1. Does the draft document adequately describe the process for gathering and evaluating the information available on occupational exposure limits or bands for engineered nanomaterials? 2. Does the draft document adequately describe the development of a framework for categorizing engineered nanomaterials by potential occupational health hazard from inhalation exposure? 3. Are the clustering and classification modeling methodologies reasonable for these data? 4. Is a revision to current occupational exposure banding guidance needed to incorporate a band F? 5. How useful and practical is the approach described in both the user guide and full technical report for deriving categorical occupational exposure limits, and what are the opportunities for improvement? 6. Are the current searches and collection of scientific data sufficient, and are there additional opportunities for obtaining data that were not included? 7. Would the methods used in the report also be appropriate for a future comprehensive dataset of experimental, toxicological, and physicochemical information for engineered nanomaterials? 8. Are there additional comments that you would like to provide? John J. Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2021–14801 Filed 7–12–21; 8:45 am] BILLING CODE 4163–18–P VerDate Sep<11>2014 17:47 Jul 12, 2021 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–7063–N] Announcement of the Advisory Panel on Outreach and Education (APOE) July 28, 2021 Virtual Meeting Centers for Medicare & Medicaid Services (CMS), Health and Human Services (HHS). ACTION: Notice. AGENCY: This notice announces the next meeting of the APOE (the Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning the Health Insurance Marketplace®, Medicare, Medicaid, and the Children’s Health Insurance Program (CHIP). This meeting is open to the public. DATES: Meeting Date: Wednesday, July 28, 2021 from 12:00 p.m. to 5:00 p.m. eastern daylight time (e.d.t). Deadline for Meeting Registration, Presentations, Special Accommodations, and Comments: Wednesday, July 14, 2021, 5:00 p.m. (e.d.t). SUMMARY: ADDRESSES: Meeting Location: Virtual. All those who RSVP will receive the link to attend. Presentations and Written Comments: Presentations and written comments should be submitted to: Lisa Carr, Designated Federal Official (DFO), Office of Communications, Centers for Medicare & Medicaid Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC 20201, 202–690–5742, or via email at APOE@ cms.hhs.gov. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the website https://www.eventbrite.com/e/ apoe-july-28-2021-virtual-meetingtickets-151112584809 or by contacting the DFO listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 36749 contact the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal Official, Office of Communications, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC 20201, 202–690–5742, or via email at APOE@cms.hhs.gov. Additional information about the APOE is available at: https:// www.cms.gov/Regulations-andGuidance/Guidance/FACA/APOE. Press inquiries are handled through the CMS Press Office at (202) 690–6145. SUPPLEMENTARY INFORMATION: I. Background and Charter Renewal Information A. Background The Advisory Panel for Outreach and Education (APOE) (the Panel) is governed by the provisions of the Federal Advisory Committee Act (FACA) (Pub. L. 92–463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (the Act) (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen’s Advisory Panel on Medicare Education 1 (the predecessor to the APOE) on January 21, 1999 (64 FR 7899) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105–33). The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) (Pub. L. 108–173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. CMS has had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and policy input from a variety of private 1 We note that the Citizen’s Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. E:\FR\FM\13JYN1.SGM 13JYN1 jbell on DSKJLSW7X2PROD with NOTICES 36750 Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Patient Protection and Affordable Care Act (Pub. L. 111–148) and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111–152) (collectively referred to as the Affordable Care Act) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and CHIP. Qualified individuals and qualified employers are now able to purchase private health insurance coverage through a competitive marketplace, called an Affordable Insurance Exchange (also called Health Insurance Marketplace®, or Marketplace® 2). In order to effectively implement and administer these changes, we must provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through the Marketplace®. The APOE (the Panel) allows us to consider a broad range of views and information from interested audiences in connection with this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. The scope of this Panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA) (Pub. L. 111–5). On January 21, 2011, the Panel’s charter was renewed and the Panel was renamed the Advisory Panel for 2 Health Insurance Marketplace®SM and Marketplace®SM are service marks of the U.S. Department of Health and Human Services. VerDate Sep<11>2014 17:47 Jul 12, 2021 Jkt 253001 Outreach and Education. The Panel’s charter was most recently renewed on January 19, 2021, and will terminate on January 19, 2023 unless renewed by appropriate action. B. Charter Renewal In accordance with the January 19, 2021, charter, the APOE will advise the HHS and CMS on developing and implementing education programs that support individuals who are enrolled in or eligible for Medicare, Medicaid, CHIP, or coverage available through the Health Insurance Marketplace® and other CMS programs. The scope of this FACA group also includes advising on education of providers and stakeholders with respect to health care reform and certain provisions of the HITECH Act enacted as part of the ARRA. The charter will terminate on January 19, 2023, unless renewed by appropriate action. The APOE was chartered under 42 U.S.C. 217a, section 222 of the Public Health Service Act, as amended. The APOE is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. In accordance with the renewed charter, the APOE will advise the Secretary and the CMS Administrator concerning optimal strategies for the following: • Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, the CHIP, and coverage available through the Health Insurance Marketplace® and other CMS programs. • Enhancing the federal government’s effectiveness in informing Medicare, Medicaid, CHIP, or the Health Insurance Marketplace® consumers, issuers, providers, and stakeholders, pursuant to education and outreach programs of issues regarding these programs, including the appropriate use of publicprivate partnerships to leverage the resources of the private sector in educating beneficiaries, providers, partners and stakeholders. • Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Medicare, Medicaid, the CHIP and the Health Insurance Marketplace® education programs, and other CMS programs as designated. • Assembling and sharing an information base of ‘‘best practices’’ for helping consumers evaluate health coverage options. • Building and leveraging existing community infrastructures for information, counseling, and assistance. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 • Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. The current members of the Panel as of June 3, 2021, are: E. Lorraine Bell, Chief Officer, Population Health, Catholic Charities USA; Nazleen Bharmal, Medical Director of Community Partnerships, Cleveland Clinic; Julie Carter, Senior Federal Policy Associate, Medicare Rights Center; Scott Ferguson, Director of Care Transitions and Population Health, Mount Sinai St. Luke’s Hospital; Leslie Fried, Senior Director, Center for Benefits Access, National Council on Aging; Jean-Venable Robertson Goode, Professor, Department of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University; Ted Henson, Director of Health Center Performance and Innovation, National Association of Community Health Centers; Joan Ilardo, Director of Research Initiatives, Michigan State University, College of Human Medicine; Cheri Lattimer, Executive Director, National Transitions of Care Coalition; Cori McMahon, Vice President, Tridiuum; Alan Meade, Director of Rehabilitation Services, Holston Medical Group; Michael Minor, National Director, H.O.P.E. HHS Partnership, National Baptist Convention USA, Incorporated; Jina Ragland, Associate State Director of Advocacy and Outreach, AARP Nebraska; Morgan Reed, Executive Director, Association for Competitive Technology; Margot Savoy, Chair, Department of Family and Community Medicine, Temple University Physicians; Congresswoman Allyson Schwartz, President and CEO, Better Medicare Alliance; and; Tia Whitaker, Statewide Director, Outreach and Enrollment, Pennsylvania Association of Community Health Centers. II. Provisions of This Notice In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the July 28, 2021 meeting will include the following: • Welcome and listening session with CMS leadership • Recap of the previous (May 26, 2021) meeting • CMS programs, initiatives, and priorities E:\FR\FM\13JYN1.SGM 13JYN1 Federal Register / Vol. 86, No. 131 / Tuesday, July 13, 2021 / Notices • An opportunity for public comment • Meeting summary, review of recommendations, and next steps Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make an oral presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. III. Meeting Participation The meeting is open to the public, but attendance is limited to registered participants. Persons wishing to attend this meeting must register at the website https://www.eventbrite.com/e/apoe-july28-2021-virtual-meeting-tickets151112584809 or contact the DFO at the address or number listed in the FOR FURTHER INFORMATION CONTACT section of this notice by the date specified in the DATES section of this notice. This meeting will be held virtually. Individuals who are not registered in advance will be unable to attend the meeting. IV. Collection of Information jbell on DSKJLSW7X2PROD with NOTICES This document does not impose information collection requirements, that is, reporting, recordkeeping, or third-party disclosure requirements. Consequently, there is no need for review by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). The Administrator of the Centers for Medicare & Medicaid Services (CMS), Chiquita Brooks-LaSure, having reviewed and approved this document, authorizes Lynette Wilson, who is the Federal Register Liaison, to electronically sign this document for purposes of publication in the Federal Register. Dated: June 30, 2021. Lynette Wilson, Federal Register Liaison, Centers for Medicare & Medicaid Services. [FR Doc. 2021–14830 Filed 7–12–21; 8:45 am] BILLING CODE 4120–01–P VerDate Sep<11>2014 17:47 Jul 12, 2021 Jkt 253001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS–2567] Emergency Clearance: Public Information Collection Requirements Submitted to the Office of Management and Budget (OMB) Centers for Medicare & Medicaid Services, Health and Human Services. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is requesting that this information collection request (ICR), for revisions to the form CMS– 2567 be processed under the emergency Paperwork Reduction Act of 1995 (PRA) clearance process. DATES: Comments must be received by August 12, 2021. ADDRESSES: When commenting, please reference the document identifier (CMS–2567) or OMB control number (0938–0391). To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, Attention: CMS–R–39/OMB Control Number 0938–0365, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at https://www.cms.hhs.gov/ PaperworkReductionActof1995. SUMMARY: FOR FURTHER INFORMATION CONTACT: William Parham, Reports Clearance Office at (410) 786–1326. SUPPLEMENTARY INFORMATION: In December, 2020, Congress passed the Consolidated Appropriations Act, 2021 (CAA, 2021). Section 407 of CAA, 2021, amended Part A of Title XVIII of the Social Security Act (the Act) at section 1822 establishing hospice program PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 36751 survey and enforcement requirements. This amendment, in part, now requires the Accrediting Organizations (AOs) that accredit hospice programs to include the form CMS–2567 to document the findings of their hospice program surveys beginning on October 1, 2021. Public harm is reasonably likely to ensue if the normal, non-emergency clearance procedures are followed. CMS would miss the statutorily mandated deadline of October 1, 2021 for Accrediting Organizations (AOs), with a hospice program, to begin using the form CMS–2567. AOs will not have the revised form to include in their current survey documentation systems and processes and will not meet the deadline of October 1, 2021 for beginning use. If CMS misses the deadline, it will jeopardize another CAA, 2021 mandated provision deadline for public posting of these AO hospice program survey reports on our website. The purpose of this requirement is for public transparency of survey and certification information. This statutory provision requires that the hospice program survey reports be posted by no later than October 1, 2022. Additionally, the public may not have all the information necessary to make an informed decision regarding where they seek high quality, safe care hospice program organizations for themselves or loved ones. Beneficiaries and the public at large utilize survey findings when evaluating whether to receive care from certain facilities. Under the PRA, federal agencies are required to publish notice in the Federal Register concerning each proposed ICR. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this ICR including the necessity and utility of the proposed ICR for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Contents This notice sets out a summary of the use and burden associated with the following ICR. More detailed information can be found in the collection’s supporting statement and associated materials (see ADDRESSES). CMS–2567 Statement of Deficiency and Plan of Correction Under the PRA (44 U.S.C. 3501– 3520), federal agencies must obtain approval from the Office of Management E:\FR\FM\13JYN1.SGM 13JYN1

Agencies

[Federal Register Volume 86, Number 131 (Tuesday, July 13, 2021)]
[Notices]
[Pages 36749-36751]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14830]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[CMS-7063-N]


Announcement of the Advisory Panel on Outreach and Education 
(APOE) July 28, 2021 Virtual Meeting

AGENCY: Centers for Medicare & Medicaid Services (CMS), Health and 
Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces the next meeting of the APOE (the Panel) 
in accordance with the Federal Advisory Committee Act. The Panel 
advises and makes recommendations to the Secretary of the U.S. 
Department of Health and Human Services (HHS) (the Secretary) and the 
Administrator of the Centers for Medicare & Medicaid Services (CMS) on 
opportunities to enhance the effectiveness of consumer education 
strategies concerning the Health Insurance Marketplace[supreg], 
Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). 
This meeting is open to the public.

DATES: 
    Meeting Date: Wednesday, July 28, 2021 from 12:00 p.m. to 5:00 p.m. 
eastern daylight time (e.d.t).
    Deadline for Meeting Registration, Presentations, Special 
Accommodations, and Comments: Wednesday, July 14, 2021, 5:00 p.m. 
(e.d.t).

ADDRESSES:
    Meeting Location: Virtual. All those who RSVP will receive the link 
to attend.
    Presentations and Written Comments: Presentations and written 
comments should be submitted to: Lisa Carr, Designated Federal Official 
(DFO), Office of Communications, Centers for Medicare & Medicaid 
Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC 
20201, 202-690-5742, or via email at [email protected].
    Registration: The meeting is open to the public, but attendance is 
limited to the space available. Persons wishing to attend this meeting 
must register at the website https://www.eventbrite.com/e/apoe-july-28-2021-virtual-meeting-tickets-151112584809 or by contacting the DFO 
listed in the FOR FURTHER INFORMATION CONTACT section of this notice, 
by the date listed in the DATES section of this notice. Individuals 
requiring sign language interpretation or other special accommodations 
should contact the DFO at the address listed in the ADDRESSES section 
of this notice by the date listed in the DATES section of this notice.

FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal 
Official, Office of Communications, 200 Independence Avenue SW, 
Mailstop 325G HHH, Washington, DC 20201, 202-690-5742, or via email at 
[email protected].
    Additional information about the APOE is available at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE. Press 
inquiries are handled through the CMS Press Office at (202) 690-6145.

SUPPLEMENTARY INFORMATION:

I. Background and Charter Renewal Information

A. Background

    The Advisory Panel for Outreach and Education (APOE) (the Panel) is 
governed by the provisions of the Federal Advisory Committee Act (FACA) 
(Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of federal advisory committees. The 
Panel is authorized by section 1114(f) of the Social Security Act (the 
Act) (42 U.S.C. 1314(f)) and section 222 of the Public Health Service 
Act (42 U.S.C. 217a).
    The Secretary of the U.S. Department of Health and Human Services 
(HHS) (the Secretary) signed the charter establishing the Citizen's 
Advisory Panel on Medicare Education \1\ (the predecessor to the APOE) 
on January 21, 1999 (64 FR 7899) to advise and make recommendations to 
the Secretary and the Administrator of the Centers for Medicare & 
Medicaid Services (CMS) on the effective implementation of national 
Medicare education programs, including with respect to the 
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 
(Pub. L. 105-33).
---------------------------------------------------------------------------

    \1\ We note that the Citizen's Advisory Panel on Medicare 
Education is also referred to as the Advisory Panel on Medicare 
Education (65 FR 4617). The name was updated in the Second Amended 
Charter approved on July 24, 2000.
---------------------------------------------------------------------------

    The Medicare Prescription Drug, Improvement, and Modernization Act 
of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan 
options and benefits available under the M+C program and renamed it the 
Medicare Advantage (MA) program. CMS has had substantial 
responsibilities to provide information to Medicare beneficiaries about 
the range of health plan options available and better tools to evaluate 
these options. The successful MA program implementation required CMS to 
consider the views and policy input from a variety of private

[[Page 36750]]

sector constituents and to develop a broad range of public-private 
partnerships.
    In addition, Title I of the MMA authorized the Secretary and the 
Administrator of CMS (by delegation) to establish the Medicare 
prescription drug benefit. The drug benefit allows beneficiaries to 
obtain qualified prescription drug coverage. In order to effectively 
administer the MA program and the Medicare prescription drug benefit, 
we have substantial responsibilities to provide information to Medicare 
beneficiaries about the range of health plan options and benefits 
available, and to develop better tools to evaluate these plans and 
benefits.
    The Patient Protection and Affordable Care Act (Pub. L. 111-148) 
and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-
152) (collectively referred to as the Affordable Care Act) expanded the 
availability of other options for health care coverage and enacted a 
number of changes to Medicare as well as to Medicaid and CHIP. 
Qualified individuals and qualified employers are now able to purchase 
private health insurance coverage through a competitive marketplace, 
called an Affordable Insurance Exchange (also called Health Insurance 
Marketplace[supreg], or Marketplace[supreg] \2\). In order to 
effectively implement and administer these changes, we must provide 
information to consumers, providers, and other stakeholders through 
education and outreach programs regarding how existing programs will 
change and the expanded range of health coverage options available, 
including private health insurance coverage through the 
Marketplace[supreg]. The APOE (the Panel) allows us to consider a broad 
range of views and information from interested audiences in connection 
with this effort and to identify opportunities to enhance the 
effectiveness of education strategies concerning the Affordable Care 
Act.
---------------------------------------------------------------------------

    \2\ Health Insurance Marketplace[supreg]SM and 
Marketplace[supreg]SM are service marks of the U.S. 
Department of Health and Human Services.
---------------------------------------------------------------------------

    The scope of this Panel also includes advising on issues pertaining 
to the education of providers and stakeholders with respect to the 
Affordable Care Act and certain provisions of the Health Information 
Technology for Economic and Clinical Health (HITECH) Act enacted as 
part of the American Recovery and Reinvestment Act of 2009 (ARRA) (Pub. 
L. 111-5).
    On January 21, 2011, the Panel's charter was renewed and the Panel 
was renamed the Advisory Panel for Outreach and Education. The Panel's 
charter was most recently renewed on January 19, 2021, and will 
terminate on January 19, 2023 unless renewed by appropriate action.

B. Charter Renewal

    In accordance with the January 19, 2021, charter, the APOE will 
advise the HHS and CMS on developing and implementing education 
programs that support individuals who are enrolled in or eligible for 
Medicare, Medicaid, CHIP, or coverage available through the Health 
Insurance Marketplace[supreg] and other CMS programs. The scope of this 
FACA group also includes advising on education of providers and 
stakeholders with respect to health care reform and certain provisions 
of the HITECH Act enacted as part of the ARRA.
    The charter will terminate on January 19, 2023, unless renewed by 
appropriate action. The APOE was chartered under 42 U.S.C. 217a, 
section 222 of the Public Health Service Act, as amended. The APOE is 
governed by provisions of Public Law 92-463, as amended (5 U.S.C. 
Appendix 2), which sets forth standards for the formation and use of 
advisory committees.
    In accordance with the renewed charter, the APOE will advise the 
Secretary and the CMS Administrator concerning optimal strategies for 
the following:
     Developing and implementing education and outreach 
programs for individuals enrolled in, or eligible for, Medicare, 
Medicaid, the CHIP, and coverage available through the Health Insurance 
Marketplace[supreg] and other CMS programs.
     Enhancing the federal government's effectiveness in 
informing Medicare, Medicaid, CHIP, or the Health Insurance 
Marketplace[supreg] consumers, issuers, providers, and stakeholders, 
pursuant to education and outreach programs of issues regarding these 
programs, including the appropriate use of public-private partnerships 
to leverage the resources of the private sector in educating 
beneficiaries, providers, partners and stakeholders.
     Expanding outreach to vulnerable and underserved 
communities, including racial and ethnic minorities, in the context of 
Medicare, Medicaid, the CHIP and the Health Insurance 
Marketplace[supreg] education programs, and other CMS programs as 
designated.
     Assembling and sharing an information base of ``best 
practices'' for helping consumers evaluate health coverage options.
     Building and leveraging existing community infrastructures 
for information, counseling, and assistance.
     Drawing the program link between outreach and education, 
promoting consumer understanding of health care coverage choices, and 
facilitating consumer selection/enrollment, which in turn support the 
overarching goal of improved access to quality care, including 
prevention services, envisioned under the Affordable Care Act.
    The current members of the Panel as of June 3, 2021, are: E. 
Lorraine Bell, Chief Officer, Population Health, Catholic Charities 
USA; Nazleen Bharmal, Medical Director of Community Partnerships, 
Cleveland Clinic; Julie Carter, Senior Federal Policy Associate, 
Medicare Rights Center; Scott Ferguson, Director of Care Transitions 
and Population Health, Mount Sinai St. Luke's Hospital; Leslie Fried, 
Senior Director, Center for Benefits Access, National Council on Aging; 
Jean-Venable Robertson Goode, Professor, Department of Pharmacotherapy 
and Outcomes Science, School of Pharmacy, Virginia Commonwealth 
University; Ted Henson, Director of Health Center Performance and 
Innovation, National Association of Community Health Centers; Joan 
Ilardo, Director of Research Initiatives, Michigan State University, 
College of Human Medicine; Cheri Lattimer, Executive Director, National 
Transitions of Care Coalition; Cori McMahon, Vice President, Tridiuum; 
Alan Meade, Director of Rehabilitation Services, Holston Medical Group; 
Michael Minor, National Director, H.O.P.E. HHS Partnership, National 
Baptist Convention USA, Incorporated; Jina Ragland, Associate State 
Director of Advocacy and Outreach, AARP Nebraska; Morgan Reed, 
Executive Director, Association for Competitive Technology; Margot 
Savoy, Chair, Department of Family and Community Medicine, Temple 
University Physicians; Congresswoman Allyson Schwartz, President and 
CEO, Better Medicare Alliance; and; Tia Whitaker, Statewide Director, 
Outreach and Enrollment, Pennsylvania Association of Community Health 
Centers.

II. Provisions of This Notice

    In accordance with section 10(a) of the FACA, this notice announces 
a meeting of the APOE. The agenda for the July 28, 2021 meeting will 
include the following:

 Welcome and listening session with CMS leadership
 Recap of the previous (May 26, 2021) meeting
 CMS programs, initiatives, and priorities

[[Page 36751]]

 An opportunity for public comment
 Meeting summary, review of recommendations, and next steps

    Individuals or organizations that wish to make a 5-minute oral 
presentation on an agenda topic should submit a written copy of the 
oral presentation to the DFO at the address listed in the ADDRESSES 
section of this notice by the date listed in the DATES section of this 
notice. The number of oral presentations may be limited by the time 
available. Individuals not wishing to make an oral presentation may 
submit written comments to the DFO at the address listed in the 
ADDRESSES section of this notice by the date listed in the DATES 
section of this notice.

III. Meeting Participation

    The meeting is open to the public, but attendance is limited to 
registered participants. Persons wishing to attend this meeting must 
register at the website https://www.eventbrite.com/e/apoe-july-28-2021-virtual-meeting-tickets-151112584809 or contact the DFO at the address 
or number listed in the FOR FURTHER INFORMATION CONTACT section of this 
notice by the date specified in the DATES section of this notice. This 
meeting will be held virtually. Individuals who are not registered in 
advance will be unable to attend the meeting.

IV. Collection of Information

    This document does not impose information collection requirements, 
that is, reporting, recordkeeping, or third-party disclosure 
requirements. Consequently, there is no need for review by the Office 
of Management and Budget under the authority of the Paperwork Reduction 
Act of 1995 (44 U.S.C. Chapter 35).
    The Administrator of the Centers for Medicare & Medicaid Services 
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this 
document, authorizes Lynette Wilson, who is the Federal Register 
Liaison, to electronically sign this document for purposes of 
publication in the Federal Register.

    Dated: June 30, 2021.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2021-14830 Filed 7-12-21; 8:45 am]
BILLING CODE 4120-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.